Linked Life Data

16275653

Source:http://linkedlifedata.com/resource/pubmed/id/16275653

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2006-1-23
pubmed:abstractText
The primary objective of this study was to investigate the tolerability, efficacy and pharmacokinetic profile of oral fludarabine phosphate in relapsed patients with indolent B-cell non-Hodgkin's lymphoma (B-NHL).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0923-7534
pubmed:author
pubmed:issnType
Print
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
330-3
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Phase I and pharmacokinetic study of oral fludarabine phosphate in relapsed indolent B-cell non-Hodgkin's lymphoma.
pubmed:affiliation
Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, and Hematology Division, National Cancer Center Hospital, Tokyo, Japan. yoshioga@is.icc.u-tokai.ac.jp
pubmed:publicationType
Journal Article, Clinical Trial, Clinical Trial, Phase I